Funds · GENB

Who owns GENB?

Institutional ownership of Generate Biomedicines Inc. from Form 13F, Q2 2026

85 institutional managers reported holding Generate Biomedicines Inc. (GENB) in Form 13F filings for Q2 2026, with 37,372,632 shares worth $631M. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 7,221,367 shares (+24.0%). 42 opened new positions and 13 sold out.

Funds holding
85
Value held
$631M
New / sold out
42 / 13
Net shares, same filers
+24.0%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of GENB

FundValueShare of 13F holdingsSharesMove
FMR LLC$88.1M14.0%5,221,599Added
Capital World Investors$71.1M11.3%4,215,632Added
Braidwell LP$55.4M8.8%3,283,844Trimmed
Price T Rowe Associates Inc$36.4M5.8%2,156,627Added
Norges Bank$35.3M5.6%2,094,616New
ARCH Venture Management, LLC$32.8M5.2%1,944,426Unchanged
HarbourVest Partners LLC$29.1M4.6%1,722,210Unchanged
BlackRock, Inc.$28.0M4.4%1,659,966New
Baker Bros. Advisors LP$24.0M3.8%1,423,602Unchanged
JPMorgan Chase & Co$23.8M3.8%1,409,649Trimmed
Deep Track Capital, LP$22.5M3.6%1,333,815New
ARK Investment Management LLC$21.7M3.4%1,284,617Added
Vanguard Capital Management LLC$19.1M3.0%1,132,750Added
Harvard Management Co Inc$18.7M3.0%1,111,100Unchanged
Nvidia Corp$14.1M2.2%833,325Unchanged
Davern Capital Partners, LP$13.9M2.2%824,679Added
Siren, L.L.C.$12.4M2.0%736,104Unchanged
Geode Capital Management, LLC$12.4M2.0%735,003Added
State Street Corp$8.9M1.4%526,565New
Affinity Asset Advisors, LLC$6.7M1.1%400,000Added
Morgan Stanley$6.4M1.0%377,994Added
UBS Group AG$5.5M0.9%326,273Trimmed
Sphera Funds Management LTD.$4.1M0.7%245,000Added
Charles Schwab Investment Management Inc$3.8M0.6%224,602New
Northern Trust Corp$3.3M0.5%197,543New

Share of 13F holdings is each fund's shares as a share of the 37,372,632 GENB shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. Norges Bank New+$35.3M
  2. BlackRock, Inc. New+$28.0M
  3. Deep Track Capital, LP New+$22.5M
  4. FMR LLC Added+$16.9M
  5. Vanguard Capital Management LLC Added+$16.9M
  6. ARK Investment Management LLC Added+$13.3M
  7. Geode Capital Management, LLC Added+$10.4M
  8. State Street Corp New+$8.9M
  9. Davern Capital Partners, LP Added+$3.9M
  10. Charles Schwab Investment Management Inc New+$3.8M

Biggest sellers in Q2 2026

  1. JPMorgan Chase & Co Trimmed-$26.0M
  2. Alyeska Investment Group, L.P. Sold out-$6.3M
  3. Millennium Management LLC Trimmed-$6.0M
  4. Braidwell LP Trimmed-$5.2M
  5. ExodusPoint Capital Management, LP Sold out-$3.9M
  6. Goldman Sachs Group Inc Trimmed-$2.7M
  7. CenterBook Partners LP Trimmed-$2.3M
  8. Jane Street Group, LLC Sold out-$1.5M
  9. Silverarc Capital Management, LLC Sold out-$1.3M
  10. D. E. Shaw & Co., Inc. Sold out-$1.2M

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $189M and sold $60.7M; 24 added and 10 trimmed.

Schedule 13D and 13G filings on GENB

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about GENB ownership

Who owns GENB stock?
85 institutional investment managers reported GENB positions in their Form 13F filings for Q2 2026, holding 37,372,632 shares worth $631M in total. FMR LLC reported the largest position.
Are funds buying or selling GENB?
In Q2 2026, 42 managers opened new GENB positions, 24 added, 10 trimmed and 13 sold out. Managers that filed in both quarters added a net 7,221,367 shares.
How current is this GENB institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to GENB by CUSIP. Options are left out. GENB news and filings · GENB insider trades · Top funds